Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients
Clinical trial NCT01811472 · COMPLETED
Trial details
- NCT number
- NCT01811472
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.